The POSITIVE trial assessed the safety of pausing endocrine therapy for pregnancy in HR-positive early breast cancer patients. Breastfeeding did not increase short-term breast cancer recurrence risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results